JPRN-UMIN000003492
Completed
Phase 4
Efficacy and safety of regular treatment with procaterol and budesonide inhalation suspension for young children with moderate persistent asthma. - Budesonide + Procaterol Inhalation Therapy Study (BUPIT study)
niversity of Toyama, Faculty of Medicine, Department of Pediatrics0 sites50 target enrollmentApril 14, 2010
ConditionsBronchial Asthma
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Bronchial Asthma
- Sponsor
- niversity of Toyama, Faculty of Medicine, Department of Pediatrics
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients who have an event listed below within a month a)Respiratory infection disease that required hospitalization b)Administration of systemic corticosteroids 2\.Recieving regular use of inhaled corticosteroids or beta 2 agonists in the previous 3 months 3\.Patients who have severe chronic diseases 4\.Patients who have chronic low airway diseases other than bronchial asthma 5\.Any other children considered by the attending physicians as inappropriate for participation in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
frequent skin ekectrical stimulation for Leber hereditary optic neuropathyeber Hereditary Optic NeuropathyJPRN-jRCTs052200033akamura Makoto15
Active, not recruiting
Phase 1
Safety and efficacy of combination treatment with rituximab and leflunomide in patients with active rheumatoid arthritis - Rituximab and Leflunomide in RAEUCTR2005-004582-41-GBniversity of Leeds15
Completed
Not Applicable
The efficacy and safety of combination therapy of adoptive immunotherapy with chemotherapy for advanced pancreatic cancerJPRN-UMIN000011177Tokai University School of Medicine20
Active, not recruiting
Phase 1
Study of the efficacy and safety of Lcr Regenerans®_GynoCans.EUCTR2013-002480-26-PLBIOSE234
Active, not recruiting
Phase 1
Study of the efficacy and safety of treatment administered intravaginallyin the treatment of bacterial vaginosis.Bacterial vaginosisMedDRA version: 19.0Level: LLTClassification code 10046960Term: Vaginosis bacterialSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]EUCTR2015-004563-37-PLaboratoires IPRAD PHARMA530